Tickers

JBLU — Ticker Eval done nvidia/nemotron-3-ultra-550b-a55b:free

Requested 2026-09-23 06:27:32.754204 UTC · finished 2026-09-23 06:32:12.669820 UTC

1. Composite Trajectory Verdict

Given JBLU's capital-intensive airline model with high fixed costs, significant debt obligations, and reliance on operating cash flow to fund fleet commitments, the income statement and cash flow statement carry roughly equal weight for assessing operating performance and liquidity generation, while the balance sheet reflects leverage and fleet financing obligations.

Composite Trajectory: Mixed

Annual GAAP results show a year-over-year improvement in operating loss (from $(684)M to $(368)M) and net loss (from $(795)M to $(602)M) in 2025 versus 2024, but both remain significantly worse than 2023 levels (operating loss $(230)M, net loss $(310)M) (10-K 2025, Consolidated Statements of Operations). Adjusted (non-GAAP) operating loss widened from $(93)M in 2024 to $(338)M in 2025 (10-K 2025, Regulation G Reconciliation). Quarterly Q2 2026 results show revenue growth of 14.5% YoY but operating loss widened to $(141)M from $6M operating income in Q2 2025, driven by an 80.7% increase in fuel expense (10-Q 2026-06-30, MD&A Operating Expenses). Operating cash flow turned negative in 2025 ($(94)M) after positive $144M in 2024 and $400M in 2023 (10-K 2025, Consolidated Statements of Cash Flows). Working capital swung from a $377M surplus to a $1.2B deficit (10-K 2025, MD&A Liquidity). These offsetting trends — revenue growth and GAAP loss improvement annually versus adjusted margin deterioration and quarterly margin compression — produce a mixed trajectory.

2. Red Flags

  • Operating cash flow deteriorated from $400M (2023) to $144M (2024) to $(94)M (2025) (10-K 2025, Consolidated Statements of Cash Flows).
  • Working capital shifted from a $377M surplus at Dec 31, 2024 to a $1.2B deficit at Dec 31, 2025 (10-K 2025, MD&A Liquidity and Capital Resources).
  • Interest expense increased 60.8% YoY to $588M in 2025, primarily due to TrueBlue® financing (10-K 2025, MD&A Other Income (Expense)).
  • Adjusted operating margin (non-GAAP) deteriorated from (1.0)% in 2024 to (3.7)% in 2025 (10-K 2025, Regulation G Reconciliation).
  • Q2 2026 operating loss of $(141)M vs operating income of $6M in Q2 2025, with CASM increasing 17.0% YoY to 16.53 cents (10-Q 2026-06-30, MD&A Operating Expenses, Operational Statistics).
  • Total stockholders' equity declined 19.7% from $2,641M to $2,120M between Dec 2024 and Dec 2025 (10-K 2025, Consolidated Balance Sheets).
  • Current maturities of long-term debt doubled from $392M to $769M, including $325M of 0.50% convertible senior notes due 2026 (10-K 2025, Consolidated Balance Sheets).
  • Net loss per share increased to $(1.66) in 2025 from $(0.93) in 2023 (10-K 2025, Consolidated Statements of Operations).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual GAAP operating loss improved from $(684)M in 2024 to $(368)M in 2025 but remained wider than the $(230)M loss in 2023 (10-K 2025, Consolidated Statements of Operations). Total operating revenue declined for a second consecutive year, from $9,615M (2023) to $9,279M (2024) to $9,062M (2025) (10-K 2025, Consolidated Statements of Operations). Adjusted (non-GAAP) operating loss widened each year: $(33)M (2023), $(93)M (2024), $(338)M (2025) (10-K 2025, Regulation G Reconciliation). Quarterly Q2 2026 showed revenue growth of 14.5% YoY to $2,697M but operating loss of $(141)M versus $6M operating income in Q2 2025, with operating margin falling from 0.3% to (5.2)% (10-Q 2026-06-30, MD&A Operating Revenues, Operating Expenses). Six-month 2026 net loss of $(566)M nearly doubled the $(282)M loss in the prior-year period (10-Q 2026-06-30, MD&A Overview).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

Net cash provided by operating activities declined from $400M (2023) to $144M (2024) to $(94)M (2025) (10-K 2025, Consolidated Statements of Cash Flows). For the six months ended June 30, 2026, operating cash flow was $(35)M versus $(1)M in the prior-year period (10-Q 2026-06-30, MD&A Analysis of Cash Flows). Investing cash flow swung to positive $658M in 2025 from $(3,080)M in 2024, driven by $1.5B in net proceeds from investment securities and $279M from asset sales (10-K 2025, Consolidated Statements of Cash Flows). Financing cash flow turned negative in 2025 at $(417)M after $3,767M inflow in 2024, reflecting $461M in debt repayments versus $2.8B in TrueBlue® financing proceeds in 2024 (10-K 2025, Consolidated Statements of Cash Flows). Unrestricted cash and equivalents remained roughly flat at $1.9B year-end 2025 versus 2024 but declined to $1.7B by June 30, 2026 (10-K 2025, Consolidated Balance Sheets; 10-Q 2026-06-30, Consolidated Balance Sheets).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Total assets decreased slightly from $16,841M to $16,570M between Dec 2024 and Dec 2025 (10-K 2025, Consolidated Balance Sheets). Current assets fell 24% from $4,258M to $3,238M, primarily due to a $1.5B reduction in current investment securities (from $1,689M to $213M) (10-K 2025, Consolidated Balance Sheets). Current liabilities rose 13% from $3,881M to $4,402M, driven by a doubling of current maturities of long-term debt to $769M (10-K 2025, Consolidated Balance Sheets). Long-term debt and finance lease obligations declined modestly from $8,147M to $7,729M (10-K 2025, Consolidated Balance Sheets). Total stockholders' equity fell 19.7% from $2,641M to $2,120M, with retained earnings dropping from $1,319M to $717M (10-K 2025, Consolidated Balance Sheets). By June 30, 2026, unrestricted cash fell to $1.656B from $1.946B at Dec 2025, and working capital deficit widened to $1.4B from $1.2B (10-Q 2026-06-30, Consolidated Balance Sheets; MD&A Working Capital).

6. Data Gaps

  • Q1 2026, Q3 2025, and Q1 2025 quarterly income statement, cash flow, and balance sheet details (10-Qs for 2026-03-31, 2025-09-30, 2025-06-30 not fully provided in filings).
  • Full quarterly cash flow statements for Q2 2026 (only six-month aggregates provided in 10-Q 2026-06-30).
  • Quarterly non-GAAP reconciliations for periods prior to Q2 2025.
  • Detailed debt maturity profile beyond the contractual obligations table for June 30, 2026.
  • Segment-level profitability or geographic performance trends beyond annual geographic revenue split.
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status